PCALCL: therapies and results
| Therapy . | References . | No. of patients . | CR, no. (%) . | Relapse rate, no. (%) . |
|---|---|---|---|---|
| SE | 8,21,,,–25,27,–29,36 | 53 | 27/27 (100) | 19/44 (43) |
| RT | 8,21,–23,25,30,,,,–35 | 32 | 19/20 (95) | 9/22 (41) |
| Multiagent chemotherapy | 21,24,25,27,28,37,39,,,–43,45,57,102,103 | 53 | 35/39 (90) | 16/26 (62) |
| Therapy . | References . | No. of patients . | CR, no. (%) . | Relapse rate, no. (%) . |
|---|---|---|---|---|
| SE | 8,21,,,–25,27,–29,36 | 53 | 27/27 (100) | 19/44 (43) |
| RT | 8,21,–23,25,30,,,,–35 | 32 | 19/20 (95) | 9/22 (41) |
| Multiagent chemotherapy | 21,24,25,27,28,37,39,,,–43,45,57,102,103 | 53 | 35/39 (90) | 16/26 (62) |